You are here

  • Home
  • Impact
  • Publications
  • A cost-effectiveness comparison of olanzapine and risperidone in the treatment of schizophrenia in Italy

A cost-effectiveness comparison of olanzapine and risperidone in the treatment of schizophrenia in Italy

Beard, S., Lothgren, M., Giudi, L., Ramacciotti, F., Nardini, M., & Berardi, D. (2002). A cost-effectiveness comparison of olanzapine and risperidone in the treatment of schizophrenia in Italy. Value in Health, 5(6), 515-515.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Nanoparticle technology for respiratory tract mucosal vaccine delivery
Article

A housing mobility program's impacts on teen and young adult parenting
Article

Genetic testing
Book

Using scanner data for food policy research

RTI uses cookies to offer you the best experience online. By continuing to use our website, you agree to the use of cookies. If you would like to know more about cookies and how to manage them please view our Privacy Policy. Learn More.

Got it!